Karyopharm Therapeutics Inc.

MA · United States · Reporting entity ID 100000806841

Total reported 2019–2025

$57.4M

#156 of 2,960 reporting companies — 0.1% of all reported industry payments

$7.93M in general payments across 29,773 records, plus $49.4M in research funding across 11,041 records.

How it breaks down

General payments $7,933,189

Research funding $49,443,430

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.